Dialysis News and Research

Latest Dialysis News and Research

TNF receptors 1 and 2 may predict kidney disease in diabetes

Levels of certain blood proteins indicate which diabetes patients will likely develop life-threatening kidney problems in the future, according to two studies appearing in an upcoming issue of the Journal of the American Society Nephrology.

20 Jan 2012

Study examines effect of MELD score-based allocation on post-liver transplant kidney failure

Research from the University of Michigan Health System shows the risk for kidney failure among liver transplant recipients is higher following the implementation of Model of End Stage Liver Disease (MELD), a policy change in 2002 that altered how liver transplant allocation is decided.

18 Jan 2012

UI chemists debunk misconception about amphotericin

With one simple experiment, University of Illinois chemists have debunked a widely held misconception about an often-prescribed drug.

17 Jan 2012

MYTHOS clinical trial demonstrates superiority of RenalGuard in reducing CIN

PLC Systems Inc., a company focused on innovative medical device technologies, today announced that final results from the MYTHOS investigator-sponsored clinical trial of RenalGuard in Italy have been published in the January 2012 issue of JACC – Cardiovascular Interventions, a peer-reviewed journal of the American College of Cardiology.

13 Jan 2012

Many seniors with kidney disease are good candidates for transplants

Thousands more American senior citizens with kidney disease are good candidates for transplants and could get them if physicians would get past outdated medical biases and put them on transplant waiting lists, according to a new study by Johns Hopkins researchers.

13 Jan 2012

Roundup: SEC pursuing managed care execs in Fla.; Minn. emergency medical assistance program ends; Ore. lawmakers consider reforming medical liability laws

The U.S. Securities and Exchange Commission is going after some former WellCare Health Plans executives in federal civil court regarding their alleged actions concerning WellCare's managed-care contracts for behavioral health in the state of Florida. In 2010, WellCare agreed to pay about $334 million to settle legal actions with various entities related to an alleged $40 million, five-year pattern of fraud in those contracts without admitting or denying any wrongdoing.

12 Jan 2012

State roundup: Ga. moves to keep docs; Ore. health plan could save $3.2B

The federal government sharply criticized New York's oversight of the developmentally disabled in a new report, saying the state agency charged with oversight lacks independence from the governor's office, failed to account for how it is spending public money and has broken several requirements of federal law.

12 Jan 2012

First Edition: January 11, 2012

In today's headlines, the 26 states opposed to the health law have filed their Supreme Court arguments against the measure's Medicaid expansion.

11 Jan 2012

Shire, Janssen enter development and marketing agreement for Resolor

Shire plc, the global specialty biopharmaceutical company, announced today that it has acquired the rights to develop and market Resolor (prucalopride) in the United States (US) in an agreement with Janssen Pharmaceutica N.V.

11 Jan 2012

Shire acquires rights to develop and market Resolor in the U.S.

10 Jan 2012

Urinary biomarkers can diagnose AKI in high-risk patients

Acute kidney injury (AKI) has severe consequences, with a 25 to 80 percent risk of in-hospital death. Researchers have found a way to diagnose AKI using a urine test, enabling emergency departments to identify these high-risk patients when they first arrive at the hospital.

10 Jan 2012

Viewpoints: Protecting home health workers; Minn. plans cuts in health safety net

President Obama is proposing an adjustment to laws governing working conditions for approximately 2 million workers whose job is helping elderly and disabled people with such basic tasks as eating, caring for their wounds and doing physical therapy. Under the Obama proposal, these workers would have to be paid at least a minimum wage and overtime, bringing them under the aegis of the Fair Labor Standards Act. Some Republicans are opposed to the measure, complaining that it will be expensive and may hurt the people it is intended to help.

6 Jan 2012

Solar power can make hemodialysis treatments more environmentally friendly

Solar power can help offset high utility costs and make hemodialysis treatments more environmentally friendly, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.

6 Jan 2012

Pharmalink raises SEK 35 million to further advance Nefecon and Busulipo

Pharmalink AB, today announces it has raised SEK 35 million through a rights issue of new shares to the Company's existing shareholders, including Industrifonden.

4 Jan 2012

Chart trends for bone and mineral metabolism in CKD

BioTrends Research Group, LLC has released findings from the 2011 ChartTrends: Bone and Mineral Metabolism in Chronic Kidney Disease report, the fifth in an on-going annual series. The study was conducted with 204 U.S. nephrologists who completed detailed chart reviews for 1,037 patients in CKD Stage 3, 4 and 5 not yet on dialysis.

29 Dec 2011

FMCNA recognizes 25 dialysis patients across the nation

The nation's leading network of dialysis facilities is recognizing more than 25 patients across the nation who will be 100 years or older in 2012 and are still leading healthy, fulfilling lives without their kidney function.

26 Dec 2011

Ariz. eyeing first budget surplus in four years; Wis. study finds low Medicare, Medicaid rates shift costs

Here's something Arizona hasn't seen in a while: a state budget surplus. Estimates range from $416 million to as much as $650 million when the new budget year starts in July. ... "We'll fund population increases in K-12, AHCCCS (the state's Medicaid program) and prisons," said House Appropriations Chairman John Kavanagh, who's starting his fourth year as budget chairman.

20 Dec 2011

ASN joins ABIM Foundation's Choosing Wisely campaign

The American Society of Nephrology (ASN), the world's leading kidney organization, joins the American Board of Internal Medicine (ABIM) Foundation, eight other leading national medical specialty societies and Consumer Reports in the Choosing Wisely campaign. This campaign will help physicians, patients and other health care professionals address overuse of health care resources in the United States.

15 Dec 2011

$Celgene reports final results from REVLIMID-rituximab combination phase II study for relapsed/refractory CLL$

Celgene reports final results from REVLIMID-rituximab combination phase II study for relapsed/refractory CLL

Celgene International Sàrl, a subsidiary of Celgene Corporation, (NASDAQ: CELG), announced final results from a phase II investigational study evaluating the combination of REVLIMID® (lenalidomide) and rituximab in 59 patients with relapsed or refractory chronic lymphocytic leukemia (CLL). These data were presented at the 53rd Annual Meeting of the American Society of Hematology in San Diego, CA.

14 Dec 2011

Researchers uncover important source of inflammation for CKD

UC Irvine researchers have uncovered an important source of inflammation seen in people with chronic kidney disease, which is increasingly common due to the epidemic of obesity-related diabetes and hypertension.

14 Dec 2011